Thyroid-associated ophthalmopathy
Showing 1 - 25 of >10,000
Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)
Recruiting
- Tocilizumab
- Thyroid Associated Ophthalmopathy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Oct 11, 2023
Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)
Recruiting
- Graves Ophthalmopathy
- +8 more
- Doxycycline hyclate
- Placebo
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 16, 2021
Thyroid Associated Ophthalmopathy Trial in Guangzhou (Doxycycline Hyclate)
Recruiting
- Thyroid Associated Ophthalmopathy
- Doxycycline Hyclate
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 7, 2021
Thyroid Associated Ophthalmopathy Trial in Guangzhou (immunosuppressive agent)
Recruiting
- Thyroid Associated Ophthalmopathy
- immunosuppressive agent
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 7, 2021
Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)
Not yet recruiting
- Thyroid-Associated Ophthalmopathy
- Sirolimus 1 mg Oral Tablet
- Methylprednisolone
- (no location specified)
Mar 18, 2022
Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)
Recruiting
- Graves Ophthalmopathy
- +2 more
- Simvastatin 40mg
-
Malmö, SwedenDpt. of Endocrinology, SUS Malmö
Nov 17, 2021
Thyroid Associated Ophthalmopathy Trial in Guangzhou (combination of orbital compression surgery and strabismus surgery, orbital
Not yet recruiting
- Thyroid Associated Ophthalmopathy
- combination of orbital compression surgery and strabismus surgery
- orbital compression
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Jun 6, 2021
Thyroid Associated Ophthalmopathy, Surgical Procedure, Unspecified Trial in Manresa (3D printing model/guide., Standard surgery)
Recruiting
- Thyroid Associated Ophthalmopathy
- Surgical Procedure, Unspecified
- 3D printing model/guide.
- Standard surgery
-
Manresa, Barcelona, SpainEduard Pedemonte Sarrias
Mar 8, 2022
Associated With Mental Fatigue in Graves' Disease
Recruiting
- Graves Disease
- +4 more
-
Gothenburg, SwedenDepartment of Endocrinology, Sahlgrenska University Hospital
Jan 4, 2023
Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)
Completed
- Thyroid Associated Orbitopathy
- Methotrexate
- Triamcinolone Acetonide
-
Cairo, EgyptCairo University
Jul 15, 2022
Clinical Activity of TAO Using Periocular Images Taken by
Completed
- Thyroid Eye Disease
- taking periorbital selfie images using smartphones
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Feb 15, 2023
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,
Recruiting
- Thyroid Eye Disease
- +11 more
- Linsitinib
- Placebo
-
Beverly Hills, California
- +22 more
Jan 30, 2023
Thyroid Associated Ophthalmopathy Trial in Guangzhou (Glucocorticoids)
Recruiting
- Thyroid Associated Ophthalmopathy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
May 15, 2021
Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)
Completed
- Thyroid Associated Ophthalmopathy
- Hypercholesterolemia
-
Pisa, ItalyOspedale Cisanello-Endocrinology I and II
Aug 12, 2021
Thyroid Associated Ophthalmopathies Trial (Sodium selenate, Sugar pill)
Withdrawn
- Thyroid Associated Ophthalmopathies
- Sodium selenate
- Sugar pill
- (no location specified)
Aug 12, 2021
Thyroid-Associated Ophthalmopathy Trial in Alicante (Lanreotide (Autogel formulation). Duration of treatment - 3 injections, 1
Terminated
- Thyroid-Associated Ophthalmopathy
- Lanreotide (Autogel formulation). Duration of treatment - 3 injections, 1 every 28 days
-
Alicante, SpainHospital General d'Alacant
Jun 1, 2020
Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)
Not yet recruiting
- Thyroid Eye Disease
- VRDN-001 10 mg/kg Drug:
- (no location specified)
Sep 7, 2023
Ophthalmopathy, Thyroid-Associated Trial in Gothenburg, Mölndal, Stockholm (Rituximab, Iv Methylprednisolone, peroral
Active, not recruiting
- Ophthalmopathy, Thyroid-Associated
- Rituximab
- +2 more
-
Gothenburg, Sweden
- +4 more
Sep 17, 2021
Thyroid-associated Ophthalmopathy, Dry Eye Syndrome Trial in Vienna (Methylprednisolone, Esomeprazole)
Completed
- Thyroid-associated Ophthalmopathy
- Dry Eye Syndrome
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Feb 19, 2020
Thyroid Eye Disease, TED Trial in Shanghai (IBI311)
Recruiting
- Thyroid Eye Disease, TED
-
Shanghai, Shanghai, ChinaNinth People's Hospital Affiliated to Shanghai Jiao Tong Univers
Nov 9, 2023
Customized Multiple Orbital Wall Decompression for
Recruiting
- Thyroid Eye Disease
- Modified multiple orbital wall decompression
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Nov 17, 2022
Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)
Recruiting
- Thyroid Eye Disease
- TOUR006 - 20 MG
- +2 more
-
Miami, FloridaSite - 0103
Oct 11, 2023